Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors [NA]
Completed update for the BurnAlong Pilot Study evaluating a program for adolescent and young adult cancer survivors. The study spans multipl…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Safety Study of MGAH22 in HER2-positive Carcinomas [Phase 1]
This clinical trial update reports a Phase 1 safety study of MGAH22 in HER2-positive carcinomas, which has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Multicenter Hologic Tomosynthesis Study [NA]
A multicenter tomosynthesis study sponsored by Hologic for breast cancer imaging has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: IIT2020-20-SHIRAZIP-WALK: Nature Walks [NA]
The IIT2020-20-SHIRAZIP-WALK trial sponsored by Cedars-Sinai Medical Center has completed, studying breast cancer and several hematologic ma…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk
This document reports the completion of a clinical trial studying the progression of breast cancer in men and assessing relapse risk.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer [Phase 1, Phase 2]
Completed Phase 1/2 trial evaluating H3B-6545 in women with locally advanced or metastatic ER-positive, HER2-negative breast cancer; results…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Sexual Coercion in Breast Cancer Patients Treated With Luteinizing Hormone-Releasing Hormone Agonists (LHRHa ) [NA]
This clinical trial update reports a completed study on sexual coercion among breast cancer patients treated with luteinizing hormone-releas…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Nipple Aspirate Fluid in Detecting Breast Cancer [NA]
This clinical trial evaluated nipple aspirate fluid as a potential method to detect breast cancer across multiple AJCC stages; the study is …
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Marker Technique Comparison in Targeted Axillary Dissection [NA]
A completed clinical trial evaluating marker techniques for targeted axillary dissection in breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Sexual Health Empowerment for Women's Health [NA]
Clinical trial update on a study focused on sexual health empowerment for women's health, with results posted in 2025 and involving cervical…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer [Phase 1]
A Phase 1b/2 clinical trial evaluating TTI-101 in combination for metastatic hormone receptor-positive, HER2-negative breast cancer has been…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests. [Phase 2]
A Phase 2 trial in metastatic HER2-positive breast cancer is investigating whether treatment can be reduced for patients who have undetectab…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Male breAsT cAncer preDisposition Factor
This is a completed clinical trial investigating a predisposition factor for male breast cancer. The sponsor is Institut Claudius Regaud.
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes [Phase 2]
Phase II trial evaluating the combination of pembrolizumab and eribulin in patients with HR+/HER2- metastatic breast cancer previously treat…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: An Observational, Multicenter Study Evaluating the Safety of ReAl-lifePertuzumab and Trastuzumab Fixed Dose Combination: the RAPID Study
A completed observational multicenter study evaluating the safety of a real-world fixed-dose combination of pertuzumab and trastuzumab in br…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Symptoms Associated with Chemotherapy-Induced Peripheral Neuropathy
This update reports on a completed clinical trial investigating symptoms associated with chemotherapy-induced peripheral neuropathy in breas…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Algology in Oncology Osteopathic Support (ALGOS) [NA]
Clinical trial ALGOS (Algology in Oncology Osteopathic Support) has completed. It evaluates osteopathic support for patients with breast can…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis [Phase 2]
A Phase 2 clinical trial evaluating the combination of radiation therapy, palbociclib, and endocrine (hormone) therapy in patients with estr…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer [Phase 1, Phase 2]
Phase 1/2 neoadjuvant trial evaluating hydroxychloroquine, palbociclib, and letrozole in estrogen receptor–positive, HER2-negative breast ca…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: BostonGene and Exigent Genomic INsight Study
Clinical trial update indicates that the BostonGene-Exigent Genomic INsight study is currently recruiting participants across indications in…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer [Phase 3]
A Phase 3 pharmacodynamic study of subcutaneous goserelin 3.6 mg in premenopausal breast cancer patients was terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Hypofractionated Radiation Fractionation in Breast Cancer Patients With Implant-Based Reconstruction [NA]
A clinical trial evaluating hypofractionated radiation therapy for breast cancer patients with implant-based reconstruction is currently rec…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer [NA]
A terminated clinical trial evaluating whether a structured pharmaceutical interview improves adherence to hormonotherapy in women with brea…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Clinical trial evaluating tamoxifen in women with breast cancer and in women at high risk who are taking certain antidepressants or gabapent…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation [Phase 2]
Phase 2 trial evaluating lasofoxifene in combination with abemaciclib in advanced or metastatic ER+/HER2- breast cancer with ESR1 mutation h…